Experience with fulvestrant acetate in castration-resistant prostate cancer patients.
J M
JM
Gasent Blesa
V
V
Alberola Candel
V
V
Giner Marco
V
V
Giner-Bosch
M
M
Provencio Pulla
J B
JB
Laforga Canales
D000368:Aged; D000369:Aged, 80 and over; D002369:Castration; D003131:Combined Modality Therapy; D004958:Estradiol / Q000031:analogs & derivatives* / Q000627:therapeutic use; D000077267:Fulvestrant; D006801:Humans; D008297:Male; D008875:Middle Aged; D009376:Neoplasms, Hormone-Dependent / Q000188:drug therapy* / Q000473:pathology / Q000601:surgery; D011379:Prognosis; D011471:Prostatic Neoplasms / Q000188:drug therapy* / Q000473:pathology / Q000601:surgery
D000077267:Fulvestrant; D004958:Estradiol